Dublin, Nov. 13, 2026 (GLOBE NEWSWIRE) -- "Good Practice (GxP) Training Services Market Global Report 2026" has been added to ResearchAndMarkets.com's offering.
The global good practice (GxP) training services market is experiencing rapid growth as pharmaceutical, biotechnology and life sciences organizations strengthen regulatory compliance, workforce competency and quality management. The market is projected to increase from $1.83 billion in 2025 to $2.03 billion in 2026, representing a compound annual growth rate (CAGR) of 10.8%.
Historical market growth has been supported by stringent global regulatory requirements, the expansion of pharmaceutical and biotechnology manufacturing facilities and the increasing frequency of regulatory audits and inspections. Wider adoption of structured quality management systems and the need for standardized employee training across regulated industries have also contributed to demand for GxP training services.
The good practice training services market is forecast to reach $3.08 billion by 2030, expanding at a CAGR of 11%. Growth during the forecast period is expected to be driven by artificial intelligence-powered adaptive learning, compliance automation platforms, digital credentialing and real-time competency tracking. The globalization of clinical trials and continued regulatory harmonization are also creating demand for scalable training programs that can support employees across multiple countries and operating environments.
Key GxP training market trends include the transition toward digital regulatory learning, personalized learning paths and continuous compliance validation. Cloud-based compliance training platforms are helping life sciences organizations standardize workforce education across global operations, while predictive analytics and risk-based training models allow businesses to identify competency gaps more effectively. Immersive virtual reality and augmented reality simulations are also gaining attention for training employees in high-risk clinical, laboratory and manufacturing environments.
Expanding pharmaceutical manufacturing activity is a major factor supporting the market. As production capacity increases, manufacturers must ensure that employees consistently follow regulatory requirements, documentation procedures and quality standards. GxP training services help pharmaceutical organizations protect product quality and safety while maintaining operational and audit readiness.
Industry data underscores this growth driver. According to the Institute of Chartered Accountants in England and Wales, pharmaceutical manufacturing output increased from $22.69 billion (£16.8 billion) in 2022 to $25.66 billion (£19 billion) in 2023. The increase in manufacturing output expands the scale of regulated operations and strengthens the need for effective compliance education, employee certification and standardized training programs.
Providers are responding by expanding interactive and role-based compliance learning. In March 2024, LearnGxP launched its 2024 Annual Refresher Series, an eight-part interactive program for professionals in the pharmaceutical, biotechnology and life sciences sectors. The digital modules provide updated guidance covering good manufacturing practice, good distribution practice, data integrity, quality culture and regulatory compliance.
The program is designed to improve employee engagement, reinforce standardized compliance practices and support ongoing audit preparedness. Annual refresher training is becoming increasingly important as organizations seek to validate employee knowledge continuously rather than relying exclusively on one-time certification. This shift supports stronger quality cultures and helps businesses respond to evolving regulatory expectations.
Strategic acquisitions are also shaping the GxP training services industry. In August 2024, BioPhorum acquired Brookwood Global for an undisclosed amount. The acquisition expanded BioPhorum's pharmaceutical and clinical research education capabilities, adding professional training, regulatory learning and GxP compliance services to its portfolio. The transaction reflects broader industry efforts to offer integrated training solutions for pharmaceutical and life sciences organizations.
North America was the largest region in the good practice (GxP) training services market in 2025, supported by its established pharmaceutical sector, extensive regulatory framework and strong adoption of digital learning technologies. Asia-Pacific is expected to be the fastest-growing region during the forecast period as pharmaceutical manufacturing, biotechnology investment and clinical research activity expand. The market covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries analyzed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Service Type: Onsite Training; Online Training; Blended Training; Customized Training; Compliance Consulting And Training
2) By Training Mode: Instructor Led Training; Self Paced Learning; Virtual Classroom Training; Web Based Training; Mobile Learning
3) By End User: Pharmaceutical Companies; Biotechnology Companies; Medical Device Companies; Contract Research Organizations; Contract Manufacturing Organizations; Healthcare Organizations; Food And Beverage Companies; Other End Users
Subsegments:
1) By Onsite Training: Manufacturing Site Based Training Programs; Laboratory Based Hands On Training Programs; Clinical Facility Based Training Programs
2) By Online Training: Web Based Compliance Learning Modules; Virtual Instructor Led Training Programs; Digital Self Paced Learning Programs
3) By Blended Training: Combined Classroom And Digital Learning Programs; Hybrid Regulatory Compliance Training Programs; Mixed Mode Skill Development Programs
4) By Customized Training: Role Based Personalized Training Programs; Process Specific Compliance Training Programs; Organization Specific Regulatory Training Programs
5) By Compliance Consulting And Training: Regulatory Gap Assessment And Training Programs; Audit Readiness Training And Advisory Programs
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026-2030 |
| Estimated Market Value (USD) in 2026 | $2.03 Billion |
| Forecasted Market Value (USD) by 2030 | $3.08 Billion |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | Global |
Companies Featured
- SGS SA (Life Sciences Division)
- UL Solutions (ComplianceWire)
- NSF International (Health Sciences Division)
- Charles River Laboratories (Training Division)
- LGC AXIO Proficiency Testing
- PQE Group S.r.l.
- QbD Group NV
- Regulatory Affairs Professionals Society
- Parenteral Drug Association
- SeerPharma Pty Ltd.
- PharmOut Pty Ltd.
- Qualio Technologies Inc.
- ComplianceQuest Inc.
- Blue Mountain Quality Resources LLC
- Astrix Technology Group
- Barnett International
- ComplianceOnline
- Biopharma Institute
- Biotech Primer Inc.
- Inspired Pharma Training Limited
- GxP Training Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/l8g0ev
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
